CMS issues new guidance addressing "spread pricing" in MedicaidCMS' new guidance clarifies how current regulations require “spread pricing” to be accounted for in the calculation of Medical Loss Ratios. Alembic receives FDA nod for generic PatadayOlopatadine hydrochloride ophthalmic solution, 0.2%, had a market value of $62 million for the 12 months ending December 2018, according to IQVIA data. Dr. Reddy’s introduces generic Cubicin Cubicin for injection had a market value of roughly $640.8 million for the most recent 12 months ended in March 2019, according to IQVIA data. Amerigen's generic Cuprimine gets FDA OK The Food and Drug Administration approved Cuprimine's penicillamine capsules. Mylan launches generic Tarceva Erlotinib hydrochloride tablets have a market value of roughly $212 million. higi offers free health screenings for World Hypertension Day To emphasize the importance of World Hypertension Day on May 17, higi's "This Year I Can" campaign will offer free health screenings. Teva launches generic Delzicol Delzicol delayed-release capsules have a market value of roughly $130 million, according to February 2019 IQVIA data. Walgreens Boots Alliance's new initiative supports people living with cancer Walgreens Boots Alliance and three cancer organizations are collaborating to support people living with cancer. Teva launches generic Tarceva Tarceva tablets have a market value of $202 million, according to IQVIA data as of February 2019. Lupin launches generic Onfi Clobazam tablets have a market value of roughly $479 million, according to March 2019 IQVIA data. First Previous 4 5 6 7 8 Next Last
